博拓生物1月29日获融资买入1017.75万元，融资余额2.88亿元

Group 1 - On January 29, Botao Bio's stock fell by 2.76%, with a trading volume of 103 million yuan [1] - The financing data showed that on the same day, Botao Bio had a financing purchase amount of 10.18 million yuan and a financing repayment of 14.82 million yuan, resulting in a net financing outflow of 4.64 million yuan [1] - As of January 29, the total balance of margin trading for Botao Bio was 288 million yuan, which accounted for 5.21% of its market capitalization [1] Group 2 - As of September 30, the number of shareholders of Botao Bio was 7,146, an increase of 28% compared to the previous period [2] - For the period from January to September 2025, Botao Bio reported an operating income of 308 million yuan, a year-on-year decrease of 20.76%, and a net profit attributable to shareholders of 22.26 million yuan, down 75.04% year-on-year [2] - Since its A-share listing, Botao Bio has distributed a total of 798 million yuan in dividends, with 478 million yuan distributed in the last three years [2]